Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

U
u. Lyapin G.Y. - THE PREVENTION OF THROMBFORMATION UNDER INFLUENCE OF A COMPLEX PREPARATION OF PLANT ANTICOAGULANT
u. Obergan T.Y. - THE PREVENTION OF THROMBFORMATION UNDER INFLUENCE OF A COMPLEX PREPARATION OF PLANT ANTICOAGULANT
U.D.C. Investigators  - JOINT RANGE OF MOTION (ROM) MEASUREMENTS IN PATIENTS WITH VON WILLEBRAND DISEASE COMPARED WITH NORMAL SUBJECTS
U.D.C. Project Investigators  - BASELINE QUALTIY OF LIFE (QOL) IN HEMOPHILIA PATIENTS RECEIVING CARE AT U.S. CENTERS
U.D.C. Working Group  - U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
Ucar C. - LOW-DOSE IMMUNE TOLERANCE INDUCTION IN THE TREATMENT OF PEDIATRIC HEMOPHILIA A PATIENTS WITH FACTOR VIII INHIBITORS-TURKISH EXPERIENCE
Ucar Albayrak C. - A TURKISH PATIENT WITH COMBINED DEFICIENCY OF VITAMIN K-DEPENDENT CLOTTING FACTORS
Uchiba M. - ACTIVATED PROTEIN C INCREASES TISSUE FACTOR EXPRESSION ON HUMAN UMBILICAL ENDOTHELIAL CELL BY EPCR-DEPENDENT BUT PAR-1-INDEPENDENT MANNER
Uchida T. - CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Uchida A. - REGULATION OF BREAST CANCER CELL GROWTH, METASTASIS AND ANGIOGENESIS BY PROTEIN C INHIBITOR
Uchida Y. - PLATELET VOLUME IN CORD BLOOD
Uchitel I.A. - CIRCULATING PROPLATELETS IN HEALTHY SUBJECTS AND PATIENTS
  - MODULATION OF PLATELET REACTIVITY BY ERYTHROCYTES IN CORONARY ARTERY DISEASE PATIENTS TAKING ASPIRIN
Uchiyama S. - RISK FACTOR PROFILE AND PATTERN OF USE OF MEDICATIONS IN JAPANESE PATIENTS AT A HIGH RISK OF CARDIOVASCULAR DIEASE: RESULTS FROM THE JAPAN THROMBOSIS REGISTRY FOR ATRIAL FIBRILLATION, CORONARY AND CEREBROVASCULAR DISEASE (J-TRACE)
Udata C. - REFORMULATED RECOMBINANT FACTOR IX: EFFICACY AND SAFETY IN PREVIOUSLY TREATED PATIENTS WITH MODERATELY SEVERE TO SEVERE HEMOPHILIA B
Udre I. - DNR ANALYSIS RESULTS IN THROMBOSES PATIENTS: THE FIRST DATA IN LATVIA
Udvardy M. - POLYCYTHAEMIA VERA, ANTIPHOSPHOLPID ANTIBODIES AND ACQUIRED PLATELET FUNCTION ABNORMALITIES
Udvardy M.L. - VWF FUNCTIONS, ADAMTS-13 ACTIVITY AND ANTIGEN LEVELS IN PATIENTS WITH LIVER CIRRHOSIS
  - QUANTITATION OF VON WILLEBRAND FACTOR MULTIMER DISTRIBUTION BY DENSITOMETRY
Ueland T. - ELEVATED SERUM LEVELS OF LIGHT IN PULMONARY ARTERIAL HYPERTENSION-POTENTIAL INVOLVEMENT IN THROMBUS FORMATION
Uemoto S. - REGULATION OF PROTEIN S EXPRESSION IN HEPATOCYTES AND SINUSOIDAL ENDOTHELIAL CELLS IN RATS WITH CIRRHOSIS
Uemura M. - ANALYSIS OF ADAMTS13 IN PATIENTS WITH COLLAGEN DISEASE-ASSOCIATED TMAS
Ueshima S. - EFFECT OF SYNTHETIC PEPTIDES DERIVED FROM STAPHYLOKINASE ON THE ACTIVATION OF PLASMINOGEN
Uetsuka Y. - OPTIMAL ANTICOAGULANT INTENSITY FOR JAPANESE PATIENTS WITH MECHANICAL VALVE
  - THE RISK FACTORS FOR THROMBOEMBOLISM IN PATIENTS WITH MECHANICAL VALVE
Ueyama M. - THE PROGRESS AND CHARACTERISTICS OF DISSEMINATED INTRAVASCULAR COAGULATION DIAGNOSED BY NEWLY ESTABLISHED DIAGNOSTIC CRITERIA FOR CRITICALLY ILL PATIENTS
Ufacik O. - IS PLATELET HYPERREACTIVITY DEFINING STICKY PLATELET SYNDROME A GLOBAL PHENOMENON? THE STUDY OF DETERMINATON OF NORMAL VALUES IN TURKISH HEALTHY SUBJECTS
Uhrin P. - ISG12 REGULATES ACTIVITY OF NUCLEAR RECEPTORS THEREBY MODULATING THE VASCULAR RESPONSE TO INJURY
Uitte de Willige S. - POLYMORPHISMS IN THE 3'-END OF THE FIBRINOGEN GAMMA GENE AND RISK OF VENOUS THROMBOEMBOLISM IN THE AFRICAN-AMERICAN AND CAUCASIAN POPULATION
  - SELECTIN HAPLOTYPES AND THE RISK OF VENOUS THROMBOSIS; INFLUENCE OF LINKAGE DISEQUILIBRIUM WITH THE FACTOR V LEIDEN MUTATION
Uknis A.B. - ELEVATED PLASMA LEVELS OF THROMBOSPONDIN-1 (TSP1) ARE ASSOCIATED WITH INCREASED LEVELS OF TGF-BETA AND PRO-INFLAMMATORY CYTOKINES IN RHEUMATOID ARTHRITIS PATIENTS
Ulfhammer E. - IL-1BETA-INDUCED TISSUE-TYPE PLASMINOGEN ACTIVATOR SUPPRESSION IN VASCULAR ENDOTHELIAL CELLS IS MEDIATED BY NF-KAPPAB SIGNALING
Ulitina A. - THE VITAMIN K EPOXIDE REDUCTASE GENE POLYMORPHISMS AND PHARMACOGENETICS OF WARFARIN
Ullmann E.F. - CLINICALLY SUSPECTED ACUTE RECURRENT PULMONARY EMBOLISM: A DIAGNOSTIC CHALLENGE
Ullrychova J. - LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Ulrich C. - COUNTS OF CD14++CD16+ MONOCYTES PREDICT CARDIOVASCULAR EVENTS IN DIALYSIS PATIENTS
Ulrich O. - RECOMBINANT ACTIVATED FACTOR VII IN THE TREATMENT OF ACUTE POST PARTUM HEMORRHAGE: THE ITALIAN REGISTRY
Ulrichts H. - A NOVEL COMPLETE HIGH SHEAR RATE ARTERIAL THROMBOSIS AND BLEEDING MODEL IN BABOONS
Ulucakli O. - THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS
Ulutin T. - DNA REPAIR GENE XRCC1 AND XPD POLYMORPHISMS AND THEIR ASSOCIATION WITH CORONARY ARTERY DISEASE RISKS AND MICRONUCLEUS FREQUENCY
Ulvinge J. - CHARACTERISATION OF THE ACTIVE FORM OF THE NOVEL ORAL DIRECT THROMBIN INHIBITOR AZD0837 IN COAGULATION ASSAYS
Umemura K. - THE EFFECTS OF BLOCKING P2Y12 RECEPTOR IN ARTEROSCLEROSIS PRODUCED BY MURINE ALLO-TRANSPALANTATION
  - EVALUATION OF LASER-INDUCED THROMBOLYSIS IN THE RAT THROMBOSIS MODELS: A PULSED GREEN LASER TECHNIQUE
Unal S. - RISK FACTORS AND OUTCOME OF PEDIATRIC THROMBOTIC EPISODES IN A SINGLE CENTER
Undar B. - THE EFFECT OF EXERCISE ON FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEALTHY VOLUNTEERS
Undas A. - ASSOCIATION BETWEEN ASPIRIN RESISTANCE AND INCREASED THROMBIN GENERATION AT THE SITE OF MICROVASCULAR INJURY: THE EFFECT OF SIMVASTATIN
  - REDUCED CLOT PERMEABILITY AND SUSCEPTIBILITY TO LYSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME: EFFECTS OF INFLAMMATION AND OXIDATIVE STRESS
  - THROMBIN GENERATION IN CHRONICALLY ANTICOAGULATED PATIENTS
  - FOLIC ACID ADMINISTRATION AND PLATELET ACTIVATION AT THE SITE OF MICROVASCULAR INJURY IN SUBJECTS WITH ELEVATED TOTAL HOMOCYSTEINE
  - THROMBIN GENERATION PROFILES IN PATIENTS WITH ACUTE CORONARY SYNDROME AND STABLE CORONARY ARTERY DISEASE: A COMPUTATIONAL ANALYSIS
  - NO DECREASE IN THROMBIN FORMATION AT THE SITE OF MICROVASCULAR INJURY IN PATIENTS TREATED WITH CLOPIDOGREL
  - FACTOR XIA (FXIA) AND TISSUE FACTOR (TF) ACTIVITY IN PLASMA OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD)
  - CONTRIBUTION OF ALPHA-FIBRINOGEN A312 ALLELE TO DECREASED THROMBIN GENERATION IN PATIENTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING SURGERY
  - C-REACTIVE PROTEIN, LIPOPROTEIN(A) AND HOMOCYSTEINE AS CONTRIBUTORS TO FIBRIN CLOT PERMEABILITY AND LYSABILITY IN SUBJECTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING
Ungerleider R. - ABNORMAL PLATELET FUNCTION IS COMMON IN PEDIATRIC CONGENITAL CARDIAC SURGERY PATIENTS
Unlu E. - THROMBOSIS IN PATIENTS WITH LUNG CANCER AND THE EFFECTIVENESS OF LOW WARFARIN PROPHYLAXIS ON PATIENTS' SURVIVAL
Unsold R. - RISK DETERMINANTS OF NONARTERITIC ISCHEMIC OPTIC NEUROPATHY (NAION)
Unuvar A. - LOW-DOSE IMMUNE TOLERANCE INDUCTION IN THE TREATMENT OF PEDIATRIC HEMOPHILIA A PATIENTS WITH FACTOR VIII INHIBITORS-TURKISH EXPERIENCE
Uprichard J. - ATTEMPTED ERADICATION OF HIGH RESPONDING FVIII INHIBITOR BY ALLOGENEIC BONE MARROW TRANSPLANTATION
Urano T. - MODIFICATION BY PAI-1 OF SLOW EXOCYTOTIC DYNAMICS OF TISSUE PLASMINOGEN ACTIVATOR (TPA) AND ITS ACTIVITY ON VASCULAR ENDOTHELIAL CELLS (VECS)
Urban A. - ASSOCIATION OF VENOUS THROMBOEMBOLISM AND OLANZAPINE
Urbanus R.T. - ACTIVATION OF PLATELETS BY DIMERIC 2-GLYCOPROTEIN I REQUIRES SIGNALING VIA BOTH GLYCOPROTEIN IBalpha AND APOLIPOPROTEIN E RECEPTOR 2'
  - DIMERIC 2-GPI BINDS TO LDL-BINDING DOMAIN 1 OF APOER2. PLATELETS EXPRESS THREE 3 DIFFERENT SPLICE VARIANTS OF APOER2 OF WHICH APOER24-5 IS THE MOST ABUNDANT
  - A DIMER OF B2GLYCOPROTEIN I (B2GPI) UPREGULATES TISSUE FACTOR (TF) AND IS THROMBOGENIC IN VIVO
  - PSGL1 AND LDL-RECEPTORS MEDIATE ADHESION OF LEUKOCYTES TO BETA2-GLYCOPROTEIN-I
Ure A. - IMPAIRED THROMBOPOIESIS AFTER STEM CELL INFECTION WITH JUNIN VIRUS
Uresandi A. - RITUXIMAB TREATMENT FOR MILD HEMOPHILIA A WITH INHIBITORS
Usami S. - MECHANISMS OF INDUCTION OF ENDOTHELIAL CELL E-SELECTIN EXPRESSION BY SMOOTH MUSCLE CELLS AND ITS INHIBITION BY SHEAR STRESS
Uslu Ö. - THE UROKINASE SYSTEM REGULATES THE MOBILIZATION, HOMING AND DIFFERENTIATION OF PROGENITOR CELLS INTO ENDOTHELIAL CELLS
Uslu O. - FACTOR VII ACTIVATING PROTEASE INHIBITS VASCULAR ENDOTHELIAL GROWTH FACTOR-MEDIATED PROGENITOR CELL HOMING AND DIFFERENTIATION INTO ENDOTHELIAL CELLS
  - FACTOR VII ACTIVATING PROTEASE INHIBITS THE UROKINASE PLASMINOGEN ACTIVATION SYSTEM AND STIMULATES GELATINASES (MATRIX METALLOPROTEINASES-2 AND -9) IN VASCULAR SMOOTH MUSCLE AND ENDOTHELIAL CELLS
Usuda S. - LOCALIZATION AND EXPRESSION OF MYOSIN VI IN HUMAN HAEMATOPOIETIC CELLS INCLUDING PLATELETS
Uzan M. - FIBRIN MONOMER BY A QUANTITATIVE ASSAY IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION
  - CUTANEOUS REACTION TO LOW MOLECULAR WEIGHT HEPARIN AND HOMOZYGOUSIS FOR FACTOR V LEIDEN MUTATION DURING PREGNANCY: A CASE REPORT
Uziel Y. - THROMBOPHILIA DOES NOT INCREASE THE RISK FOR RECURRENT THROMBOSIS IN PEDIATRIC APS
| ISTH 2009